| 报告期 | 销售毛利率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2026-03-31 | 51.79% | -10.94% | 7.79% | 73/140 | 52.37% | 迈克生物 | 57.29% | 行业排名> |
| 2025-12-31 | 48.05% | -2.64% | -12.21% | 78/140 | 51.9% | 佰仁医疗 | 88.17% | 行业排名> |
| 2025-09-30 | 54.73% | 9.67% | -9.41% | 66/140 | 52.23% | 佰仁医疗 | 89.18% | 行业排名> |
| 2025-06-30 | 60.42% | 22.06% | 3.9% | 58/140 | 52.43% | 佰仁医疗 | 88.17% | 行业排名> |
| 2025-03-31 | 58.15% | 17.73% | 17.83% | 58/140 | 52.13% | 佰仁医疗 | 88.54% | 行业排名> |
| 2024-12-31 | 49.35% | -14.3% | -1.11% | 80/140 | 53.08% | 佰仁医疗 | 85.72% | 行业排名> |
| 2024-09-30 | 49.9% | -14.2% | 0.82% | 76/140 | 53.87% | 佰仁医疗 | 88.34% | 行业排名> |
| 2024-06-30 | 49.5% | -19.13% | 0.21% | 78/140 | 53.95% | 佰仁医疗 | 88.56% | 行业排名> |
| 2024-03-31 | 49.39% | -22.97% | -14.23% | 76/140 | 53.88% | 佰仁医疗 | 89.27% | 行业排名> |
| 2023-12-31 | 57.58% | 21.28% | -1% | 59/140 | 53.57% | 佰仁医疗 | 89.28% | 行业排名> |
| 2023-09-30 | 58.16% | 26.55% | -4.97% | 60/140 | 54.44% | 正海生物 | 89.9% | 行业排名> |
| 2023-06-30 | 61.2% | 36.02% | -4.54% | 53/140 | 53.81% | 正海生物 | 90.39% | 行业排名> |
| 2023-03-31 | 64.12% | 41.18% | 35.05% | 47/140 | 54.06% | 正海生物 | 90.3% | 行业排名> |
| 2022-12-31 | 47.48% | -3.26% | 3.3% | 84/140 | 54.01% | 万泰生物 | 91.61% | 行业排名> |
| 2022-09-30 | 45.96% | -7.66% | 2.14% | 80/140 | 55.7% | 三友医疗 | 90.18% | 行业排名> |
| 2022-06-30 | 45% | -11.49% | -0.93% | 83/140 | 55.37% | 三友医疗 | 90.14% | 行业排名> |
| 2022-03-31 | 45.42% | -12.98% | -7.46% | 78/140 | 56.89% | 三友医疗 | 90.29% | 行业排名> |
| 2021-12-31 | 49.08% | -15.75% | -1.4% | 86/140 | 57.98% | 三友医疗 | 90.73% | 行业排名> |
| 2021-09-30 | 49.77% | -20.02% | -2.09% | 76/140 | 59.77% | 三友医疗 | 90.5% | 行业排名> |
| 2021-06-30 | 50.84% | -21.84% | -2.6% | 79/140 | 59.05% | 三友医疗 | 90.29% | 行业排名> |
| 2021-03-31 | 52.19% | -0.24% | -10.4% | 68/140 | 61.5% | 正海生物 | 90.78% | 行业排名> |
| 2020-12-31 | 58.25% | 23.32% | -6.4% | 76/140 | 60.12% | 正海生物 | 91.59% | 行业排名> |
| 2020-09-30 | 62.23% | 29.04% | -4.32% | 48/140 | 62.21% | 正海生物 | 92.23% | 行业排名> |
| 2020-06-30 | 65.04% | 38.49% | 37.7% | 48/140 | 60.36% | 正海生物 | 92.69% | 行业排名> |
| 2019-12-31 | 47.23% | -1.55% | -1.55% | 77/140 | 56.96% | 正海生物 | 92.61% | 行业排名> |
| 2018-12-31 | 47.98% | -2.68% | 2.15% | 68/140 | 56.22% | 正海生物 | 94.38% | 行业排名> |
| 2018-06-30 | 46.96% | 1.56% | -4.74% | 33/140 | 53.06% | 正海生物 | 93.12% | 行业排名> |
| 2017-12-31 | 49.3% | 3.25% | -5.77% | 63/140 | 56.1% | 正海生物 | 93.78% | 行业排名> |
| 2017-03-31 | 52.32% | 2% | 9.57% | 24/140 | 54.29% | 正海生物 | 93.09% | 行业排名> |
| 2016-12-31 | 47.75% | -8.79% | -0.99% | 49/140 | 57.35% | 正海生物 | 93.85% | 行业排名> |
| 2016-09-30 | 48.23% | 2% | 4.29% | 20/140 | 51.85% | 正海生物 | 93.08% | 行业排名> |
| 2016-06-30 | 46.24% | 2% | -11.67% | 26/140 | 52.6% | 正海生物 | 92.83% | 行业排名> |

微信公众号
证券之星APP


